Expense Ratio History

GMAEX expense ratio history

GMO Quality Cyclicals Fund, Class VI

Fund company
GMO
Type
Mutual fund

Expense ratio: 0.58%

In basis points
58 basis points
Yearly cost per $10,000
$58
Prospectus dated
30 June 2024, filed with the SEC; rounded to 0.01%
Last change
Raised from 0.55% on 30 June 2024

Fee over time

GMAEX expense ratio: 0.77% until 30 Jun 2021, then 0.60%; 0.60% until 30 Jun 2022, then 0.48%; 0.48% until 30 Jun 2023, then 0.55%; 0.55% until 30 Jun 2024, then 0.58%; read at 0.58% on 30 Jun 2024.0.00%0.50%1.00%1.50%Jun 2020Mar 2021Dec 2021Sep 2022Jun 2023Mar 20240.77% before0.58% from 30 Jun 2024
GMAEX expense ratio: 0.77% until 30 Jun 2021, then 0.60%; 0.60% until 30 Jun 2022, then 0.48%; 0.48% until 30 Jun 2023, then 0.55%; 0.55% until 30 Jun 2024, then 0.58%; read at 0.58% on 30 Jun 2024.0.00%0.50%1.00%1.50%Jun 2020Nov 2021Apr 20230.77% before0.58% from 30 Jun 2024
Solid line: the fee in effect after each recorded change. Dashed: the fee before it. Dots: prospectuses filed with the SEC and dates we read the fee from a source.

Share classes

The same fund is sold as 6 share classes, each with its own fee. Figures are from each class's latest prospectus in SEC filings, rounded to 0.01%.

TickerShare classFeeAfter waiversProspectus dated
GMAEX (this page) Class VI 0.58% 0.41% 30 Jun 2024
GMANX Class III 0.67% 0.50% 30 Jun 2024
— Class IV 0.63% 0.46% 30 Jun 2024
— Class V 0.61% 0.44% 30 Jun 2024
— Class R6 0.67% 0.50% 30 Jun 2024
GMAOX Class I 0.79% 0.61% 30 Jun 2024

Every figure we've recorded

DateFeeWhat happened
30 Jun 2024 0.58% In the prospectusTotal annual fund operating expenses in the prospectus dated 2024-06-30 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
30 Jun 2024 0.58% Raised from 0.55% to 0.58%Prospectus date; the new figure appears in this filingSource: Prospectus (form 485BPOS) filed with the SEC on 2024-06-28
30 Jun 2023 0.55% In the prospectusTotal annual fund operating expenses in the prospectus dated 2023-06-30 (form 497), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 497
30 Jun 2023 0.55% Raised from 0.48% to 0.55%Prospectus date; the new figure appears in this filingSource: Prospectus (form 497) filed with the SEC on 2023-07-03
30 Jun 2022 0.48% In the prospectusTotal annual fund operating expenses in the prospectus dated 2022-06-30 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
30 Jun 2022 0.48% Cut from 0.60% to 0.48%Prospectus date; the new figure appears in this filingSource: Prospectus (form 485BPOS) filed with the SEC on 2022-06-30
30 Jun 2021 0.60% In the prospectusTotal annual fund operating expenses in the prospectus dated 2021-06-30 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
30 Jun 2021 0.60% Cut from 0.77% to 0.60%Prospectus date; the new figure appears in this filingSource: Prospectus (form 485BPOS) filed with the SEC on 2021-06-30
30 Jun 2020 0.77% In the prospectusTotal annual fund operating expenses in the prospectus dated 2020-06-30 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS

What this fee costs

Change the amount, years or return. The estimate keeps the fee at 0.58% and the return steady each year, the same assumptions as the cost example in a fund's prospectus.

$727 in fees over 10 years

After fees, $10,000 grows to $15,390.

Fees paid on $10,000 at 5% a year
AfterFees paid
1 year$59
3 years$186
5 years$325
10 years$727

How we read this figure

The figure is the total annual fund operating expenses line of the fee table in the fund's prospectus, as tagged in the fund company's filing with the SEC. The SEC publishes these figures rounded to four decimal places, so 0.015% appears as 0.02%. The fund company's own page may show a more precise number.

SEC filings give 5 prospectuses for this share class since 2020. Each one is listed above with a link to the filing.

How we read fees

More GMO funds

The cheapest of 45. All GMO funds.